6. CONFLICT OF INTEREST
All members of the Female Lower Urinary Tract Symptoms (FLUTS) Guidelines Panel have provided disclosure statements of all relationships that might be perceived as a potential source of a conflict of interest. This information is published below and also publicly accessible through the European Association of Urology website: https://uroweb.org/guideline/renalcellcarcinoma/panel.
This Guidelines document was developed with the financial support of the European Association of Urology (EAU). No external sources of funding or support were involved in the development of this guideline. The EAU is a nonprofit organisation, and funding was limited to administrative, travel and meeting expenses. No honoraria or other reimbursements were provided.
Disclosures:
The EAU Guidelines Office certifies that all conflicts of interest, including specific financial interests and relationships or affiliations relevant to the subject matter discussed in the manuscript (e.g. employment/affiliation, consultancies, honoraria, grants or research support, trial participation, advisory roles, travel support or patents), are as follows:
C. Harding reported serving as a company consultant for Viatris, ConvaTec, Astellas Pharma Europe Ltd., GlaxoSmithKline, and Medtronic, and reported receiving company speaker honoraria from Boston Scientific and Viatris UK Healthcare Ltd.
M. Lapitan reported receiving company speaker honoraria from GlaxoSmithKline and Astellas. S. Arlandis reported receiving company speaker honoraria from Astellas, and receipt of honoraria or consultation fees from GlaxoSmithKline, Presurgy S.I., Allergan, ITALFARMACO, and Boston Scientific Ibérica. E. Costantini reported serving as a company consultant and as participation in a company sponsered speaker's bureau with Pierre Fabre Pharma and reporting congress participation with Ibsa Farmaceutici Italia Srl. A. Nambiar reported receiving honoraria or consultation fees from Medtronic and AbbVie and travel grants from Abbvie medical bv. B. Peyronnet reported serving as a company consultant for Intuitive Surgical, Boston Scientific, MEDTRONIC FRANCE, Pierre Fabre, Abbvie, Ipsen, IBSA, Coloplast, and Schwa Medico. V. Phé reported serving as a company consultant for Medtronic France, AbbVie, and Laborie. A. Riogh reported receiving company speaker honoraria from Boston Scientific and receiving fellowship or travel grants from Boston Scientific Europe. H. Cobussen-Boekhorst reported receiving company speaker honorarium from Coloplast, Wellspect Healthcare, Astellas and Hollister
K. Bo, M. De Heide, I. Omar, M.L. Van Poelgeest-Pomfret, C.W.L. Van den Bos, N.R. Bhatt, F. Farag, S. Monagas Arteaga, L. Moris, E. O'Connor, N. Sihra, and L. Tzelves all have nothing to declare.